Illumina Ownership
| ILMN Stock | USD 140.14 3.15 2.30% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 159 M | Current Value 160 M | Avarage Shares Outstanding 146.9 M | Quarterly Volatility 7.8 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Illumina |
Illumina Stock Ownership Analysis
About 95.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.62. Illumina recorded a loss per share of 9.96. The entity had not issued any dividends in recent years. The firm had 1028:1000 split on the 25th of June 2024. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company was incorporated in 1998 and is based in San Diego, California. Illumina operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 9800 people. To learn more about Illumina call Jacob Thaysen at 858 202 4500 or check out https://www.illumina.com.Besides selling stocks to institutional investors, Illumina also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Illumina's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Illumina's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Illumina Quarterly Liabilities And Stockholders Equity |
|
Illumina Insider Trades History
Less than 1% of Illumina are currently held by insiders. Unlike Illumina's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Illumina's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Illumina's insider trades
Illumina Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Primecap Management Company | 20232023-09-03 | 2.5 M | Alliancebernstein L.p. | 2024-06-30 | 2.5 M | Corvex Management Lp | 2024-09-30 | 2.3 M | Norges Bank | 2024-06-30 | 2.1 M | Nuveen Asset Management, Llc | 2024-06-30 | 1.9 M | Bank Of America Corp | 2024-06-30 | 1.6 M | Legal & General Group Plc | 2024-06-30 | 1.6 M | Hhg Plc | 2024-06-30 | 1.5 M | Millennium Management Llc | 2024-06-30 | 1.5 M | Blackrock Inc | 2024-06-30 | 18.1 M | Vanguard Group Inc | 2024-09-30 | 15.9 M |
Illumina Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jacob Thaysen over a month ago Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3 | ||
Jacob Thaysen over two months ago Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3 | ||
Ullem Scott B. over six months ago Acquisition by Ullem Scott B. of 163 shares of Illumina at 137.682 subject to Rule 16b-3 | ||
Roy Whitfield over a year ago Exercise or conversion by Roy Whitfield of 800 shares of Illumina subject to Rule 16b-3 |
Illumina's latest congressional trading
Congressional trading in companies like Illumina, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Illumina by those in governmental positions are based on the same information available to the general public.
| 2024-10-02 | Representative Michael C Burgess | Acquired $15K to $50K | Verify | ||
| 2024-10-01 | Representative Michael C Burgess | Acquired $15K to $50K | Verify | ||
| 2024-09-25 | Representative Michael C Burgess | Acquired $15K to $50K | Verify | ||
| 2024-09-24 | Representative Michael C Burgess | Acquired $15K to $50K | Verify | ||
| 2024-05-30 | Representative Thomas H Kean | Acquired Under $15K | Verify | ||
| 2020-04-14 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2020-04-13 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify |
Illumina Outstanding Bonds
Illumina issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Illumina uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Illumina bonds can be classified according to their maturity, which is the date when Illumina has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ILMN 255 23 MAR 31 Corp BondUS452327AM11 | View | |
| ILMN 58 12 DEC 25 Corp BondUS452327AN93 | View | |
| ILMN 575 13 DEC 27 Corp BondUS452327AP42 | View | |
| ILLUMINATE BUYER LLC Corp BondUS45232TAA97 | View | |
| ILLINOIS TOOL WKS Corp BondUS452308AR01 | View | |
| ILLINOIS TOOL WKS Corp BondUS452308AQ28 | View | |
| ILLINOIS TOOL WKS Corp BondUS452308AX78 | View |
Illumina Corporate Filings
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 7th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 15th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving against Illumina Stock
| 0.68 | VCNX | Vaccinex | PairCorr |
| 0.59 | HLN | Haleon plc | PairCorr |
| 0.52 | VALN | Valneva SE ADR | PairCorr |
| 0.49 | ERNA | Eterna Therapeutics | PairCorr |
| 0.48 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.96) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.